Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Asthma UK

This page shows the latest Asthma UK news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Limited NICE recommendation for Fasenra, Urovant takes aim at an IPO, Xtandi expands use

Daily Brief: Limited NICE recommendation for Fasenra, Urovant takes aim at an IPO, Xtandi expands use

News from pharma, biotech and healthcare. Limited NICE approval for AZ’s asthma drug Fasenra. ... However, the UK's cost-effectiveness watchdog says the drug should only be used in limited circumstances for eosinophilic asthma, when usual therapies

Latest news

  • Six new national standards are launched across UK Six new national standards are launched across UK

    The UK is welcoming a new set of national standards this coming year, which are designed to improve the quality and consistency of public involvement in research. ... The standards will be launched across ten pilot sites in the UK including Asthma UK

  • NICE backs Teva's Cinqaero for severe asthma NICE backs Teva's Cinqaero for severe asthma

    Teva's interleukin-5 (IL-5) inhibitor should be made available to patients under the NHS as an add-on therapy for patients with for severe eosinophilic asthma, says the ... Kay Boycott, chief executive of medical charity Asthma UK, welcomed the decision.

  • NICE recognises Smartinhaler as best practice for asthma care NICE recognises Smartinhaler as best practice for asthma care

    According to Asthma UK's Annual Asthma Survey 2016 report, emergency hospital admission is 23 times more expensive than an asthma review, with the annual cost of asthma care in the ... It is shocking that [according to Asthma UK's report] 82% of UK

  • NICE changes stance on GSK's asthma drug Nucala NICE changes stance on GSK's asthma drug Nucala

    A newly-agreed price cut and additional cost-effectiveness data prompt U-turn. Patients in the UK with severe asthma are on course to be able to receive treatment with ... There are thought to be around 100, 000 people in the UK who have uncontrolled

  • AstraZeneca to explore link between epigenetics and respiratory diseases AstraZeneca to explore link between epigenetics and respiratory diseases

    Teaming up with Asthma UK, the British Lung Foundation and independent medical research charity MRC Technology, AZ hopes to discover new epigenetic treatments for people living with respiratory diseases. ... The funding and support from Asthma UK and the

More from news
Approximately 3 fully matching, plus 17 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Evoke Mind+Matter

We are Evoke Mind ‘PLUS’ Matter. The ‘plus’ is important to us because we are all about offering more for...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....

Quick links